Evidence map›Paper›PMID 39158076›Full record

ArticleBlood advances2024

Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function.

Jean-Benoît Le Luduec, Theodota Kontopoulos, M Kazim Panjwani, Rosa Sottile, Hongtao Liu, Gesine Schäfer, Carolin Massalski, Vinzenz Lange, Katharine C Hsu

Abstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jean-Benoît Le LuduecHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-1046-2941
Theodota KontopoulosHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-2054-4112
M Kazim PanjwaniHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-2305-1164
Rosa SottileHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-2950-9508
Hongtao LiuHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Gesine SchäferGenotyping Laboratory, Deutsche Knochenmarkspenderdatei Life Science Lab, Dresden, Germany.
Carolin MassalskiGenotyping Laboratory, Deutsche Knochenmarkspenderdatei Life Science Lab, Dresden, Germany.
Vinzenz LangeGenotyping Laboratory, Deutsche Knochenmarkspenderdatei Life Science Lab, Dresden, Germany.ORCID 0000-0002-6442-9573
Katharine C HsuHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Hematopopietic Stem Cell TransplantationU01AI069197 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Effie W Petersdorf · 2005 to 2026
$18.9M
NCI NIH HHS P30 CA008748NIAID NIH HHS U01 AI069197
6 · The paper itself

Abstract

abstractCD94/NKG2A is a heterodimeric receptor commonly found on natural killer (NK) and T cells, and its interaction with its ligand HLA-E on adjacent cells leads to inhibitory signaling and cell suppression. We have identified several killer cell lectin-like receptor (KLR)C1 (NKG2A) single nucleotide polymorphisms (SNPs) that are associated with NKG2A expression on NK cells, CD8+ T cells, and Vγ9/Vδ2+ T cells. Additionally, due to strong linkage disequilibrium, polymorphisms in KLRC2 (NKG2C) and KLRK1 (NKG2D) are also associated with NKG2A surface density and frequency. NKG2A surface expression correlates with single-cell NK responsiveness, and NKG2A+ NK cell frequency is associated with total NK repertoire response and inhibitability, making the identification of SNPs responsible for expression and frequency important for predicting the innate immune response. Because HLA-E expression is dependent on HLA class I signal peptides, we analyzed the relationship between peptide abundance and HLA-E expression levels. Our findings revealed a strong association between peptide availability and HLA-E expression. We identified the HLA-C killer immunoglobulin-like receptor ligand epitope as a predictive marker for HLA-ABC expression, with the HLA-C1 epitope associated with high HLA-E expression and the HLA-C2 epitope associated with low HLA-E expression. The relationship between HLA-C epitopes and HLA-E expression was independent of HLA-E allotypes and HLA-B leader peptides. Although HLA-E expression showed no significant influence on NKG2A-mediated NK education, it did affect NK cell inhibition. In summary, these findings underscore the importance of NKG2A SNPs and HLA-C epitopes as predictive markers of NK cell phenotype and function and should be evaluated as prognostic markers for diseases that express high levels of HLA-E.

Indexed as

HLA-E AntigensKiller Cells, NaturalNK Cell Lectin-Like Receptor Subfamily CPolymorphism, Single NucleotideHistocompatibility Antigens Class IHumansPhenotypeHistocompatibility Antigens Class IHLA-E AntigensNK Cell Lectin-Like Receptor Subfamily C

Identifiers

PMID39158076
PMCPMC11568789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.